Investor Relations

Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research. The Company has developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. Combining recent advances in nanofabrication, biochemistry, molecular biology, surface chemistry and optics, Pacific Biosciences has created a powerful technology platform called single molecule, real-time, or SMRT™, technology. SMRT technology enables real-time analysis of biomolecules with single molecule resolution, which has the potential to transform the understanding of biological systems by providing a window into these systems that has not previously been open for scientific study.

Recent News

July 24, 2014
Pacific Biosciences Reports Second Quarter 2014 Financial Results

MENLO PARK, Calif., July 24, 2014 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB) today reported an 89% increase in revenue to $11.4 million for the second quarter, compared ...


July 2, 2014
Pacific Biosciences of California, Inc. Second Quarter 2014 Financial Results Call

MENLO PARK, Calif., July 2, 2014 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB) will hold its quarterly conference call to discuss its Second Quarter 2014 Financial Results ...


Events & Presentations

Dec 2, 2014
The 26th Annual Piper Jaffray Healthcare Conference
Dec 3, 2014
ISI MedTools & Outsourcing Investor Forum

Stock Quote

NASDAQ (GM) : PACB
Price
$5.13
Last Trade
4:00 PM ET
Sep 16, 2014
Change
$+0.07
Change (%)
+1.383%
Volume
435,000
52 Week High
8.20
52 Week Low
3.32
Day High
5.16
Day Low
5.05

Investor
Contacts

Pacific Biosciences

1380 Willow Rd.
Menlo Park, CA 94025
(650) 521-8450
ir@pacificbiosciences.com

Supernav grey background

Supernav grey background

Super Navigation block